Company News

Nuvisan Announces Deal with Nestlé Skin Health/Galderma

Taking over parts of the R&D capacities in Sophia-Antipolis, France.

Author Image

By: Christine Esposito

Editor-in-Chief

The Nuvisan Group, a European CRO focused on early stage drug development for the life science industry, has signed an agreement with Nestlé Skin Health/Galderma to take over parts of the R&D capacities in Sophia-Antipolis, France. The Galderma R&D site in Sophia-Antipolis, which opened in 2006, is one of the world’s largest research and development center focused on medical and cosmetic solutions for the skin. The new capabilities will strengthen Nuvisan’s core service lines in bio...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters